SurgiCal Obesity Treatment Study
| ISRCTN | ISRCTN47072588 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN47072588 |
| Protocol serial number | HTA 10/42/02 |
| Sponsor | NHS Greater Glasgow and Clyde (UK) |
| Funder | NIHR Health Technology Assessment Programme - HTA (UK) (10/42/02) |
- Submission date
- 26/09/2011
- Registration date
- 30/09/2011
- Last edited
- 13/02/2024
- Recruitment status
- No longer recruiting
- Overall study status
- Ongoing
- Condition category
- Nutritional, Metabolic, Endocrine
Plain English summary of protocol
Background and study aims
Bariatric surgery is a type of surgery performed on people who are obese with the purpose of making them lose weight - this includes gastric bypass and gastric banding. It is an increasingly common operation yet the long term benefits and complications are not well known. This study will collect data on every patient in Scotland having weight loss surgery, to monitor their weight, nutrient levels in their blood, whether diabetes gets better or if they develop diabetes in the future, any complications such as wound infections or requiring a second operation, heart attacks, cancer or if they die, and if quality of life improves and they feel more or less anxious or depressed after the surgery. We will follow the patients for 10 years after their surgery.
Who can participate?
Participants will be people undergoing bariatric surgery in Scotland - either in the NHS or private hospitals.
What does the study involve?
The study will follow patients during their normal care before and after surgery. No additional tests will be performed. Results of blood tests and details of any future hospital admissions will be gathered using the data stored in Scottish NHS computer systems. For participants with diabetes, data on their diabetes control, medications and complications will be gathered again from NHS computer systems. Participants will be contacted by post before the operation and annually after the operation to complete a questionnaire on quality of life and also be asked if they have had any complications relate to their surgery. They will be phoned 30 days after surgery to be asked how they are recovering from the surgery.
What are the possible benefits and risks of participating?
There are no benefits or risks to the participants.
Where is the study run from?
The study is run by the University of Glasgow with all NHS and private hospitals providing bariatric surgery in Scotland being involved.
When is the study starting and how long is it expected to run for?
The study will start in January 2012. Participants will be recruited until January 2017 and all participants will be followed up until July 2026.
Who is funding the study?
The National Institute of Health Research Health Technology Appraisal Scheme.
Who is the main contact?
Dr Jennifer Logue
Jennifer.Logue@Glasgow.ac.uk
Contact information
Scientific
BHF Cardiovascular Research Centre
University of Glasgow
126 University Place
Glasgow
G12 9PP
United Kingdom
Study information
| Primary study design | Observational |
|---|---|
| Study design | Multi-centre prospective cohort study |
| Secondary study design | Cohort study |
| Study type | Participant information sheet |
| Scientific title | SurgiCal Obesity Treatment Study: a prospective cohort study |
| Study acronym | SCOTS |
| Study objectives | To establish in a cohort of obese patients who are undergoing bariatric surgery: 1. All cause and cause specific mortality over a mean of 10 years since bariatric surgery. 2. Incidence of cardiovascular disease, cancer and diagnosis of diabetes over a mean of 10 years since bariatric surgery 3. Incidence of acute and chronic postoperative complications. Acute complications, defined as up to three months post surgery, will include surgical site infection; chronic complications will include revisional surgery, plastic surgery and chronic pain. 4. Change in health related quality of life, anxiety and depression over time pre- and post-operatively for a mean of 10 years from date of bariatric surgery. 5. The micronutrient and weight status pre and post-operatively for a mean of 10 years since bariatric surgery. 6. The glycaemic control, lipids, blood pressure, medication prescription, and rate of diabetes complications (microalbuminuria and renal disease, retinopathy and foot ulceration) in those that have pre-existing diabetes or develop diabetes during a mean of 10 years follow up since bariatric surgery. More details can be found at http://www.nets.nihr.ac.uk/projects/hta/104202 Protocol can be found at http://www.nets.nihr.ac.uk/__data/assets/pdf_file/0018/55413/PRO-10-42-02.pdf |
| Ethics approval(s) | To be submitted to West of Scotland Reserach Ethics Commitee |
| Health condition(s) or problem(s) studied | Obesity |
| Intervention | Bariatric surgery (surgical procedures developed for the primary purpose of weight loss currently laparoscopic gastric banding, sleeve gastrectomy and roux-en-y gastric bypass) 2000 patients undergoing bariatric surgery in the NHS and private sector in Scotland, UK, over a 5-year period will be recruited. The participants will be followed up for a mean of 10 years. The mortality, weight, incident type 2 diabetes mellitus (T2DM), coronary heart disease (CHD), cardiovascular disease (CVD), cancer, fractures, nutritional blood markers, anxiety, depression, post-operative complications, revisional surgery rates, health related quality of life, glycaemic control, diabetic complications and diabetes medications will be recorded. |
| Intervention type | Other |
| Primary outcome measure(s) |
10-year mortality |
| Key secondary outcome measure(s) |
In the 10 years following bariatric surgery: |
| Completion date | 01/07/2026 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | All |
| Target sample size at registration | 2000 |
| Total final enrolment | 445 |
| Key inclusion criteria | Undergoing bariatric surgery in NHS secondary care and private practice in Scotland, UK |
| Key exclusion criteria | Does not meet inclusion criteria |
| Date of first enrolment | 01/01/2014 |
| Date of final enrolment | 01/01/2017 |
Locations
Countries of recruitment
- United Kingdom
- Scotland
Study participating centre
G12 9PP
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Data sharing statement to be made available at a later date |
| IPD sharing plan | The current data sharing plans for this study are unknown and will be available at a later date |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | 01/01/2024 | 13/02/2024 | Yes | No | |
| Protocol article | protocol | 22/05/2015 | 22/07/2020 | Yes | No |
| Interim results article | Characteristics and health and socioeconomic burden | 26/08/2021 | 31/08/2021 | Yes | No |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
| Study website | Study website | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
13/02/2024: Publication reference and total final enrolment added.
20/09/2021: Internal review.
31/08/2021: Publication reference added.
22/07/2020: The following changes were made to the trial record:
1. The publication and dissemination plan was added.
2. The IPD sharing statement was added to the publication and dissemination plan.
3. Publication reference added.
4. The trial website was added.
17/07/2020: The contact email was changed.
